Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib.
(Q39097045)
scientific article published on 11 September 2013
scientific article published on 11 September 2013
Language:
Current Data About
Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib.
other details
description | scientific article published on 11 September 2013 |
External Links
(P356) |
10.1158/1535-7163.MCT-13-0170
|
(P698) |
24026012
|